Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|7|1|46-55

ISSN: 2045-7634

Source: Cancer Medicine, Vol.7, Iss.1, 2018-01, pp. : 46-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content